Get the Stockscreener App
2.00
2.35%
0.046
After Hours:
1.96
-0.04
-2.00%
Okyo Pharma Limited stock is traded at $2.00, with a volume of 71,564.
It is up +2.35% in the last 24 hours and down -6.98% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$1.954
Open:
$1.99
24h Volume:
71,564
Relative Volume:
0.51
Market Cap:
$75.22M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-12.20
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
-1.96%
1M Performance:
-6.98%
6M Performance:
+86.92%
1Y Performance:
+94.17%
1-Day Range:
$1.96
$2.06
1-Week Range:
$1.9036
$2.31
52-Week Range:
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.00 | 73.49M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Okyo Pharma Limited Stock (OKYO) Latest News
Is a relief rally coming for OKYO Pharma Limited holdersWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
How analysts rate OKYO Pharma Limited stock todayTrade Risk Report & Smart Swing Trading Techniques - newser.com
Can OKYO Pharma Limited (OK11) stock sustain institutional flowsJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com
OKYO Pharma Limited’s volatility index tracking explainedQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Why OKYO Pharma Limited stock attracts high net worth investors2025 Major Catalysts & AI Powered Buy/Sell Recommendations - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder value2025 Performance Recap & Real-Time Chart Breakout Alerts - newser.com
What technical signals suggest for OKYO Pharma Limited stockLayoff News & Verified Short-Term Plans - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsDip Buying & Stepwise Trade Execution Plans - newser.com
OKYO Pharma (NASDAQ:OKYO) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Is OKYO Pharma Limited stock poised for growthTrade Ideas & Daily Stock Trend Reports - newser.com
Will OKYO Pharma Limited (OK11) stock sustain uptrend momentumWeekly Profit Recap & Fast Entry Momentum Trade Alerts - newser.com
Why analysts remain bullish on OKYO Pharma Limited stockMarket Growth Report & Reliable Price Action Trade Plans - newser.com
What analysts say about OKYO Pharma Limited stockStock Screening Results & Watch Expert Picks Before They Rally - earlytimes.in
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update - Defense World
Is OKYO Pharma Limited stock a top momentum playTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
What analysts say about OKYO Pharma Limited OK11 stockEx-Dividend Date Alerts & Avoid Market Traps With Pro-Level Warnings - earlytimes.in
What MACD and RSI say about OKYO Pharma LimitedJuly 2025 PostEarnings & Verified Short-Term Plans - newser.com
Statistical indicators supporting OKYO Pharma Limited’s strengthMarket Volume Summary & Safe Swing Trade Setup Alerts - newser.com
Is OKYO Pharma Limited (OK11) stock positioned for secular growth2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Using data filters to optimize entry into OKYO Pharma Limited2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-05 06:32:18 - newser.com
Can OKYO Pharma Limited (OK11) stock expand revenue streamsJuly 2025 Setups & Safe Capital Allocation Plans - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock splitJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 03:34:35 - newser.com
Is OKYO Pharma Limited (OK11) stock cheap vs fundamentalsWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Published on: 2025-10-03 05:35:24 - newser.com
How OKYO Pharma Limited (OK11) stock reacts to Fed tightening2025 Price Targets & Breakout Confirmation Trade Signals - newser.com
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):